These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 17986152)
1. Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics. Han X J Neurochem; 2007 Nov; 103 Suppl 1(Suppl 1):171-9. PubMed ID: 17986152 [TBL] [Abstract][Full Text] [Related]
2. Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease. Han X Biochim Biophys Acta; 2010 Aug; 1801(8):774-83. PubMed ID: 20117236 [TBL] [Abstract][Full Text] [Related]
3. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment. Qiu S; Palavicini JP; Wang J; Gonzalez NS; He S; Dustin E; Zou C; Ding L; Bhattacharjee A; Van Skike CE; Galvan V; Dupree JL; Han X Mol Neurodegener; 2021 Sep; 16(1):64. PubMed ID: 34526055 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's disease. Cheng H; Zhou Y; Holtzman DM; Han X Neurobiol Aging; 2010 Jul; 31(7):1188-96. PubMed ID: 18762354 [TBL] [Abstract][Full Text] [Related]
5. Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease: an early event in disease pathogenesis. Cheng H; Wang M; Li JL; Cairns NJ; Han X J Neurochem; 2013 Dec; 127(6):733-8. PubMed ID: 23865640 [TBL] [Abstract][Full Text] [Related]
6. The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease. Han X Mol Neurobiol; 2010 Jun; 41(2-3):97-106. PubMed ID: 20052565 [TBL] [Abstract][Full Text] [Related]
7. Sulfatide Deficiency, an Early Alzheimer's Lipidomic Signature, Causes Brain Ventricular Enlargement in the Absence of Classical Neuropathological Hallmarks. Palavicini JP; Ding L; Pan M; Qiu S; Wang H; Shen Q; Dupree JL; Han X Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613677 [TBL] [Abstract][Full Text] [Related]
8. Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease. Han X Curr Alzheimer Res; 2005 Jan; 2(1):65-77. PubMed ID: 15977990 [TBL] [Abstract][Full Text] [Related]
9. Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study. Cheng H; Xu J; McKeel DW; Han X Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):809-18. PubMed ID: 14528918 [TBL] [Abstract][Full Text] [Related]
10. Endosomes and lysosomes play distinct roles in sulfatide-induced neuroblastoma apoptosis: potential mechanisms contributing to abnormal sulfatide metabolism in related neuronal diseases. Zeng Y; Cheng H; Jiang X; Han X Biochem J; 2008 Feb; 410(1):81-92. PubMed ID: 17939778 [TBL] [Abstract][Full Text] [Related]
11. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. Han X; M Holtzman D; McKeel DW; Kelley J; Morris JC J Neurochem; 2002 Aug; 82(4):809-18. PubMed ID: 12358786 [TBL] [Abstract][Full Text] [Related]
12. Alterations in lipid homeostasis of mouse dorsal root ganglia induced by apolipoprotein E deficiency: a shotgun lipidomics study. Cheng H; Jiang X; Han X J Neurochem; 2007 Apr; 101(1):57-76. PubMed ID: 17241120 [TBL] [Abstract][Full Text] [Related]
13. Novel molecular insights into the critical role of sulfatide in myelin maintenance/function. Palavicini JP; Wang C; Chen L; Ahmar S; Higuera JD; Dupree JL; Han X J Neurochem; 2016 Oct; 139(1):40-54. PubMed ID: 27417284 [TBL] [Abstract][Full Text] [Related]
14. Chronic caloric restriction attenuates a loss of sulfatide content in PGC-1α-/- mouse cortex: a potential lipidomic role of PGC-1α in neurodegeneration. Kiebish MA; Young DM; Lehman JJ; Han X J Lipid Res; 2012 Feb; 53(2):273-81. PubMed ID: 22114039 [TBL] [Abstract][Full Text] [Related]
15. Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease. He S; Qiu S; Pan M; Palavicini JP; Wang H; Li X; Bhattacharjee A; Barannikov S; Bieniek KF; Dupree JL; Han X Clin Transl Med; 2023 Jul; 13(7):e1332. PubMed ID: 37478300 [TBL] [Abstract][Full Text] [Related]
16. Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content. Han X; Cheng H; Fryer JD; Fagan AM; Holtzman DM J Biol Chem; 2003 Mar; 278(10):8043-51. PubMed ID: 12501252 [TBL] [Abstract][Full Text] [Related]
17. APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain. Lefterov I; Wolfe CM; Fitz NF; Nam KN; Letronne F; Biedrzycki RJ; Kofler J; Han X; Wang J; Schug J; Koldamova R Alzheimers Res Ther; 2019 Dec; 11(1):113. PubMed ID: 31888770 [TBL] [Abstract][Full Text] [Related]
18. Alterations in mouse brain lipidome after disruption of CST gene: a lipidomics study. Wang C; Wang M; Zhou Y; Dupree JL; Han X Mol Neurobiol; 2014 Aug; 50(1):88-96. PubMed ID: 24395133 [TBL] [Abstract][Full Text] [Related]
19. Sulfatides facilitate apolipoprotein E-mediated amyloid-beta peptide clearance through an endocytotic pathway. Zeng Y; Han X J Neurochem; 2008 Aug; 106(3):1275-86. PubMed ID: 18485101 [TBL] [Abstract][Full Text] [Related]
20. Imaging mass spectrometry (IMS) of cortical lipids from preclinical to severe stages of Alzheimer's disease. Gónzalez de San Román E; Manuel I; Giralt MT; Ferrer I; Rodríguez-Puertas R Biochim Biophys Acta Biomembr; 2017 Sep; 1859(9 Pt B):1604-1614. PubMed ID: 28527668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]